Human papillomavirus (HPV)-related oropharyngeal squamous cell cancer (OPSCC) has
emerged as a distinct clinical entity of head and neck cancer with expected high survival …

Human papilloma virus (HPV) is a well-established causative factor in a subset of squamous
cell carcinomas of the head and neck (HNSCC). Although HPV can be detected in various …

Numerous trials have been launched over the prior decade examining the safety and
efficacy of therapy de-escalation in human papillomavirus (HPV)-associated oropharyngeal …

Due to the generally poor prognosis of head and neck squamous cell carcinoma (HNSCC),
treatment has been intensified, these last decades, leading to an increase of serious side …

The prevalence of oropharyngeal squamous cell carcinoma has been increasing in North
America due to human papillomavirus-associated disease. It is molecularly distinct and …

The prevalence of patients with human papilloma virus (HPV)-associated oropharyngeal
squamous cell carcinoma (OPSCC) is rapidly increasing, and it is now well known that these …

Background Human papillomavirus (HPV)-associated oropharyngeal squamous cell
carcinoma (OPSCC) has increased in incidence in recent decades. With higher cure rates in …

Abstract Human papillomavirus-related (HPV+) oropharyngeal squamous cell carcinoma
(OPSCC) is a relatively new clinical entity that is dramatically on the rise globally. HPV+ …

Human papillomavirus–associated oropharynx cancer (HPVA-OPC) is rapidly increasing in
incidence and has unique epidemiologic, molecular, and biologic characteristics. Despite …

BACKGROUND The growing epidemic of human papillomavirus‐positive (HPV+)
oropharyngeal cancer and the favorable prognosis of this disease etiology have led to a call …